BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22327468)

  • 1. Receptor for advanced glycation end products in bacterial infection: is there a role for immune modulation of receptor for advanced glycation end products in the treatment of sepsis?
    Christaki E; Lazaridis N; Opal SM
    Curr Opin Infect Dis; 2012 Jun; 25(3):304-11. PubMed ID: 22327468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumonia.
    Christaki E; Opal SM; Keith JC; Kessimian N; Palardy JE; Parejo NA; Tan XY; Piche-Nicholas N; Tchistiakova L; Vlasuk GP; Shields KM; Feldman JL; Lavallie ER; Arai M; Mounts W; Pittman DD
    Shock; 2011 May; 35(5):492-8. PubMed ID: 21263385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.
    Susa Y; Masuda Y; Imaizumi H; Namiki A
    Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.
    Liliensiek B; Weigand MA; Bierhaus A; Nicklas W; Kasper M; Hofer S; Plachky J; Gröne HJ; Kurschus FC; Schmidt AM; Yan SD; Martin E; Schleicher E; Stern DM; Hämmerling G Gü; Nawroth PP; Arnold B
    J Clin Invest; 2004 Jun; 113(11):1641-50. PubMed ID: 15173891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice.
    van Zoelen MA; Schmidt AM; Florquin S; Meijers JC; de Beer R; de Vos AF; Nawroth PP; Bierhaus A; van der Poll T
    J Infect Dis; 2009 Sep; 200(5):765-73. PubMed ID: 19627249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis.
    Bopp C; Bierhaus A; Hofer S; Bouchon A; Nawroth PP; Martin E; Weigand MA
    Crit Care; 2008; 12(1):201. PubMed ID: 18226173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Septic shock is associated with receptor for advanced glycation end products ligation of LPS.
    Yamamoto Y; Harashima A; Saito H; Tsuneyama K; Munesue S; Motoyoshi S; Han D; Watanabe T; Asano M; Takasawa S; Okamoto H; Shimura S; Karasawa T; Yonekura H; Yamamoto H
    J Immunol; 2011 Mar; 186(5):3248-57. PubMed ID: 21270403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
    van Beijnum JR; Buurman WA; Griffioen AW
    Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the role of the receptor for advanced glycation end products-ligand axis in liver injury?
    Basta G; Navarra T; De Simone P; Del Turco S; Gastaldelli A; Filipponi F
    Liver Transpl; 2011 Jun; 17(6):633-40. PubMed ID: 21438128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end product receptor-mediated cellular dysfunction.
    Bierhaus A; Humpert PM; Stern DM; Arnold B; Nawroth PP
    Ann N Y Acad Sci; 2005 Jun; 1043():676-80. PubMed ID: 16037292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress.
    Herold K; Moser B; Chen Y; Zeng S; Yan SF; Ramasamy R; Emond J; Clynes R; Schmidt AM
    J Leukoc Biol; 2007 Aug; 82(2):204-12. PubMed ID: 17513693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases.
    Mahajan N; Dhawan V
    Int J Cardiol; 2013 Oct; 168(3):1788-94. PubMed ID: 23722052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAGE in inflammation: a new therapeutic target?
    Bierhaus A; Stern DM; Nawroth PP
    Curr Opin Investig Drugs; 2006 Nov; 7(11):985-91. PubMed ID: 17117586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.
    Kim W; Hudson BI; Moser B; Guo J; Rong LL; Lu Y; Qu W; Lalla E; Lerner S; Chen Y; Yan SS; D'Agati V; Naka Y; Ramasamy R; Herold K; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2005 Jun; 1043():553-61. PubMed ID: 16037278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of the receptor for advanced glycation end products (RAGE) in inflammation].
    Mosquera JA
    Invest Clin; 2010 Jun; 51(2):257-68. PubMed ID: 20928981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor for advanced glycation end products (RAGE)-expressing endothelial cells co-express AGE and S100 in human periapical granulomas.
    Takeichi O; Hatori K; Kamimoto A; Oka S; Ogiso B; Saito I
    J Dent; 2011 Oct; 39(10):679-85. PubMed ID: 21864645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia.
    van Zoelen MA; Schouten M; de Vos AF; Florquin S; Meijers JC; Nawroth PP; Bierhaus A; van der Poll T
    J Immunol; 2009 Apr; 182(7):4349-56. PubMed ID: 19299735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited role of the receptor for advanced glycation end products during Streptococcus pneumoniae bacteremia.
    Achouiti A; de Vos AF; de Beer R; Florquin S; van 't Veer C; van der Poll T
    J Innate Immun; 2013; 5(6):603-12. PubMed ID: 23774862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of receptor for advanced glycation end products in cardiogenic shock.
    Selejan SR; Pöss J; Hewera L; Kazakov A; Böhm M; Link A
    Crit Care Med; 2012 May; 40(5):1513-22. PubMed ID: 22430238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin.
    Mahajan N; Bahl A; Dhawan V
    Int J Cardiol; 2010 Jul; 142(3):273-8. PubMed ID: 19201044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.